These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26235211)

  • 21. Stakeholder perspectives regarding pragmatic clinical trial collateral findings.
    Morain SR; Mathews DJH; Weinfurt K; May E; Bollinger JM; Geller G; Sugarman J
    Learn Health Syst; 2021 Oct; 5(4):e10245. PubMed ID: 34667872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.
    Franklin JM; Pawar A; Martin D; Glynn RJ; Levenson M; Temple R; Schneeweiss S
    Clin Pharmacol Ther; 2020 Apr; 107(4):817-826. PubMed ID: 31541454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pragmatic trials and implementation science: grounds for divorce?
    Pawson R
    BMC Med Res Methodol; 2019 Aug; 19(1):176. PubMed ID: 31420024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.
    Larson EB; Tachibana C; Thompson E; Coronado GD; DeBar L; Dember LM; Honda S; Huang SS; Jarvik JG; Nelson C; Septimus E; Simon G; Johnson KE
    Healthc (Amst); 2016 Sep; 4(3):138-41. PubMed ID: 27637816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence.
    Campbell JD; McQueen RB; Briggs A
    Ann Am Thorac Soc; 2014 Feb; 11 Suppl 2():S105-11. PubMed ID: 24559022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pragmatic trials are important to medical research].
    Bjerre E; Brasso K; Midtgaard J
    Ugeskr Laeger; 2015 Jul; 177(31):. PubMed ID: 26238009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and management of pragmatic clinical trial collateral findings: A current understanding and directions for future research.
    Morain SR; Mathews DJH; Geller G; Bollinger J; Weinfurt K; Jarvik JG; May E; Sugarman J
    Healthc (Amst); 2021 Dec; 9(4):100586. PubMed ID: 34600345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pragmatic design in randomized controlled trials.
    Purgato M; Barbui C; Stroup S; Adams C
    Psychol Med; 2015 Jan; 45(2):225-30. PubMed ID: 25065958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service.
    Debruyne PR; Johnson PJ; Pottel L; Daniels S; Greer R; Hodgkinson E; Kelly S; Lycke M; Samol J; Mason J; Kimber D; Loucaides E; Parmar MK; Harvey S;
    Clin Trials; 2015 Jun; 12(3):257-64. PubMed ID: 25652529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.
    Oude Rengerink K; Kalkman S; Collier S; Ciaglia A; Worsley SD; Lightbourne A; Eckert L; Groenwold RHH; Grobbee DE; Irving EA;
    J Clin Epidemiol; 2017 Sep; 89():173-180. PubMed ID: 28502808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using randomised controlled trials (RCTs) to test service interventions: issues of standardisation, selection and generalisability.
    Watson B; Procter S; Cochrana W
    Nurse Res; 2004; 11(3):28-42. PubMed ID: 15065482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients' Views About the Disclosure of Collateral Findings in Pragmatic Clinical Trials: a Focus Group Study.
    Bollinger JM; Geller G; Weinfurt K; May E; Morain SR; Mathews DJH; Sugarman J
    J Gen Intern Med; 2020 Dec; 35(12):3436-3442. PubMed ID: 32815061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health information technology and sociotechnical systems: a progress report on recent developments within the UK National Health Service (NHS).
    Waterson P
    Appl Ergon; 2014 Mar; 45(2):150-61. PubMed ID: 23895916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Trial Protocol Tool: The PRACTIHC software tool that supported the writing of protocols for pragmatic randomized controlled trials.
    Treweek S; McCormack K; Abalos E; Campbell M; Ramsay C; Zwarenstein M;
    J Clin Epidemiol; 2006 Nov; 59(11):1127-33. PubMed ID: 17027422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of pragmatic clinical trials in clinical evaluation of Chinese medicine].
    Wu YQ; Hu YH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1241-4. PubMed ID: 21302481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical guidelines and the pursuit of reducing epistemic uncertainty. An ethnographic study of guideline development panels in three countries.
    Wieringa S; Engebretsen E; Heggen K; Greenhalgh T
    Soc Sci Med; 2021 Mar; 272():113702. PubMed ID: 33548773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Pragmatism in Recently Published Randomized Clinical Trials.
    Janiaud P; Dal-Ré R; Ioannidis JPA
    JAMA Intern Med; 2018 Sep; 178(9):1278-1280. PubMed ID: 30039169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.